EGACY
Phase 1
Recruiting
- Conditions
- on-ST-segment elevation acute coronary syndromeTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutics [E02]
- Registration Number
- CTIS2023-504360-42-00
- Lead Sponsor
- Amsterdam UMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 3090
Inclusion Criteria
Clinical diagnosis of NSTE-ACS (i.e. NSTEMI or unstable angina), Successful PCI (according to the treating physician)
Exclusion Criteria
Known allergy or contraindication for aspirin or all commercially available P2Y12-inhibitors (i.e. ticagrelor, prasugrel and clopidogrel), Concurrent use of oral anticoagulants (e.g. because of atrial fibrillation), Ongoing indication for DAPT at admission (e.g. due to recent PCI or ACS), Planned surgical intervention within 12 months of PCI, Pregnant or breastfeeding women at time of enrolment, Participation in another trial with an investigational drug or device
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method